Replacement of the Ascending Aorta and Aortic Valve with a Composite Graft
Key result
Composite graft replacement of the ascending aorta and aortic valve resulted in a 5% hospital mortality and an 81% three-year actuarial survival rate.
Why the study?
Does composite graft replacement of the ascending aorta and aortic valve provide satisfactory survival and reoperation rates in patients with anuloaortic ectasia or aortic dissection?
Population
86 patients undergoing composite graft replacement of the ascending aorta and aortic valve, primarily for…
Design
Cohort
Follow-up
average 23.5 months (range: 0.2-60 months)
Authors
Discussion
Loading...
Member takes
Implication
May support composite grafting in anuloaortic ectasia; leaves open need for comparative trials.
Study Design
Type
Cohort (n=86)
Structured PICO
Does composite graft replacement of the ascending aorta and aortic valve provide satisfactory survival and reoperation rates in patients with anuloaortic ectasia or aortic dissection?
P
Population
86 patients undergoing composite graft replacement of the ascending aorta and aortic valve, primarily for anuloaortic ectasia (n=44) or aortic dissection (n=31).
I
Intervention
Composite graft replacement of the ascending aorta and aortic valve
O
Outcome
Hospital mortality, reoperation rate, and 3-year actuarial survivalhard clinical
Composite graft replacement of the ascending aorta and aortic valve is a safe and effective surgical option with acceptable mortality and good 3-year survival, particularly for patients with anuloaortic ectasia and aortic dissection.
Cite This Study
Kouchoukos et al. (1980) conducted a cohort in Anuloaortic ectasia and aortic dissection (n=86). Composite graft replacement of the ascending aorta and aortic valve was evaluated on Hospital mortality. Composite graft replacement of the ascending aorta and aortic valve resulted in a 5% hospital mortality and an 81% three-year actuarial survival rate.